Synta Pharmaceuticals (SNTA) Posts Narrower than Expected Q2 Loss of 25c/Share
Tweet Send to a Friend
Synta Pharmaceuticals, Inc. (NASDAQ: SNTA) reported Q2 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
